Condition: Frontotemporal Dementia · Sponsor: University Hospital, Lille
GENFI Lille is a French cohort that belongs to the international initiative GENFI2, a five year longitudinal biomarker cohort study of genetic FTD and its associated disorders (including MND/ALS) investigating members of families with a known mutation in GRN or MAPT or an expansion in C9orf72 (including those affected with the disorder as well as at-risk members of families).
This description comes directly from the study's public registry record.
Thibaud LEBOUVIER, MD, Ph · 03 20 44 60 21 · thibaud.lebouvier@chru-lille.fr
Always discuss trial participation with your own doctor first.
| Hôpital Roger Salengro, CHRU de Lille - CMRR | Lille, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04639622